Clinical outcome of switching from ranibizumab to aflibercept in the treatment of neovascular age-related macular degeneration

被引：0
|
作者：
Lu, Lin [1 ,2 ]
Muthulingam, Gnanaruban [2 ]
Osborne, Claire [2 ]
Tonne, Prabhu [2 ]
Reddy, Gopinath [2 ]
Logendran, Maharatnam [2 ]
机构：
[1] South East Midlands Deanery, Ophthalmol, Northampton, England
[2] Northampton Gen Hosp, Ophthalmol, Northampton, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
106
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Mantel, Irmela
    Gillies, Mark C.
    Souied, Eric H.
    [J]. SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
  • [2] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [3] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
  • [4] Switching from ranibizumab and aflibercept to bevacizumab therapy in neovascular age-related macular degeneration patients
    Calugaru, Dan
    Calugaru, Mihai
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : NP1 - NP2
  • [5] UK outcomes of switching patients with neovascular age-related macular degeneration from ranibizumab to aflibercept
    Manjunath, Vina
    Talks, James S.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [6] Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept
    Tyagi, Pallavi
    Juma, Zain
    Hor, Yong Keen
    Scott, Neil W.
    Ionean, Andreea
    Santiago, Cynthia
    [J]. BMC OPHTHALMOLOGY, 2018, 18
  • [7] Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept
    Pallavi Tyagi
    Zain Juma
    Yong Keen Hor
    Neil W. Scott
    Andreea Ionean
    Cynthia Santiago
    [J]. BMC Ophthalmology, 18
  • [8] Effects of Switching from Ranibizumab to Aflibercept on Visual Outcome, Lesion Activity and Treatment Intensity in Eyes with Neovascular Age-Related Macular Degeneration
    Barthelmes, Daniel
    Campain, Anna E.
    Arnold, Jennifer J.
    McAllister, Ian
    Simpson, Judy M.
    Hunyor, Alex P.
    Guymer, Robyn H.
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Marquis, Liza-Marie
    Mantel, Irmela
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1591 - 1596
  • [10] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Liza-Marie Marquis
    Irmela Mantel
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1591 - 1596
12345